Literature DB >> 9186725

Is promiscuity of G protein interaction an issue in the classification of receptors?

G Milligan1.   

Abstract

It is clear that the details of binding of different classes of agonist ligands to the same receptor may be distinct. This could result in subtle differences in the profile of G protein activation by individual ligands at the same receptor due to agonist-induced selection of conformational states of the receptor which favor interaction and ternary-complex formation with different G proteins. This can result in differences in the details of receptor pharmacology when measured at the level of effector output. Such differences are also likely to be dependent upon both the levels of expression of the receptor and the relevant G proteins and the G protein and effector enzyme isoform expression profile of a particular tissue. It would be foolish, however, to use such differences, in isolation, as a means to expand the classification of G protein-coupled receptors particularly when more molecular approaches to receptor classification are readily available.

Mesh:

Substances:

Year:  1997        PMID: 9186725     DOI: 10.1111/j.1749-6632.1997.tb48152.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Mechanisms of modulation of voltage-dependent calcium channels by G proteins.

Authors:  A C Dolphin
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

2.  P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and M-type K+ currents.

Authors:  A K Filippov; T E Webb; E A Barnard; D A Brown
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

3.  Structural mechanism underlying primary and secondary coupling between GPCRs and the Gi/o family.

Authors:  Hee Ryung Kim; Jun Xu; Shoji Maeda; Nguyen Minh Duc; Donghoon Ahn; Yang Du; Ka Young Chung
Journal:  Nat Commun       Date:  2020-06-22       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.